Roche, Mylan Settle Suit Over Generic Cancer Drug
Hoffmann-La Roche Inc. and Mylan Inc. on Tuesday reached a settlement over claims that Mylan infringed a Roche patent by marketing a generic version of cancer drug Xeloda....To view the full article, register now.
Already a subscriber? Click here to view full article